ReviewDiabetes/metabolism research and reviews2026
Exercise Modulates the Osteoimmune Axis: Myokine-Mediated Mechanisms in Diabetic Bone Disease.
Review in Diabetes/metabolism research and reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Patients with type 2 diabetes mellitus (T2DM) often present with normal or even elevated bone mineral density (BMD), yet exhibit a significantly increased fracture risk-a phenomenon referred to as the 'diabetic bone paradox'. This discrepancy underscores the inadequacy of conventional BMD-centred assessment systems in fully elucidating the mechanisms underlying bone fragility in T2DM. Current evidence suggests that T2DM-related skeletal fragility is multifactorial, involving alterations in bone quality, advanced glycation end-product (AGE) accumulation, low bone turnover, microarchitectural deterioration, diabetic complications, increased fall risk and chronic inflammation. Recent advances in osteoimmunology have revealed that immune cell polarization driven by chronic low-grade inflammation, along with an imbalanced receptor activator of nuclear factor-κB ligand/osteoprotegerin (RANKL/OPG) axis, may contribute to the dysregulation of bone remodelling in T2DM. As a cornerstone intervention in T2DM management, exercise not only acts directly on bone tissue via mechanical loading but also may exert systemic immunomodulatory effects through myokines secreted by skeletal muscle. Exercise-induced myokines, such as interleukin-6 (IL-6), irisin, β-aminoisobutyric acid (BAIBA) and interleukin-15 (IL-15), may modulate the osteoimmune microenvironment and restore the dynamic equilibrium between bone resorption and formation by modulating macrophage polarization, restoring the Th17/Treg balance, bone marrow adipose tissue metabolism, and chronic inflammatory signalling pathways. Moreover, exercise may further promote bone metabolic homoeostasis by suppressing negative regulatory signals, such as myostatin. Therefore, this narrative review summarises the aberrant features of the osteoimmune axis in T2DM, with a focus on the potential mechanisms by which exercise and its induced myokines may modulate the osteoimmune microenvironment to ameliorate diabetic bone disease, thereby providing a framework for understanding exercise as a potential non-pharmacological intervention and identifying areas requiring further translational investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.